[Dangerous thrombocytopenia in thrombolytic therapy of venous thrombosis of the leg]

[Dangerous thrombocytopenia in thrombolytic therapy of venous thrombosis of the leg] Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

[Dangerous thrombocytopenia in thrombolytic therapy of venous thrombosis of the leg] Abstract Text:

M Fischer,J Tempel,G Schenker,

Two days after 5 days heparin treatment of a superficial thrombophlebitis a 45 year old woman was admitted to hospital with an extended phlebothrombosis of a leg. Before starting thrombolytic treatment a bolus of 5000 U heparin followed by 1000 U/h was administered. During thrombolytic treatment with ultrahigh streptokinase the platelet count dropped from 172,000/microliter to 73,000 and 29,000/microliter. Thrombocytopenia was considered not to be a complication of thrombolytic therapy but by demonstrating heparin induced platelet antibodies to be due to a heparin-associated thrombocytopenia type II (HAT Type II).

[Dangerous thrombocytopenia in thrombolytic therapy of venous thrombosis of the leg] Publishing Authors By Initials

M Fischer,J Tempel,G Schenker,

For similar cardiovascular diseases: vascular diseases: embolism and thrombosis: thrombosis: venous thrombosis: thrombophlebitis research abstracts see: cardiovascular diseases: vascular diseases: embolism and thrombosis: thrombosis: venous thrombosis: thrombophlebitis research

PUBMED ID PMID:

MEDLINE DATE:

[Dangerous thrombocytopenia in thrombolytic therapy of venous thrombosis of the leg] Journal Published:

PUBLICATION TYPE: Journal Article

Journal: VASA. Zeitschrift für Gefässkrankheiten. Journal f

VOLUME: 26

Page Numbers: 235-8

Journal Abbreviation: VASA

ISSN: 0301-1526

DAY: 13

MONTH: Aug

YEAR: 1997

[Dangerous thrombocytopenia in thrombolytic therapy of venous thrombosis of the leg] Information

Number of References:

LANGUAGE: ger

NlmUniqueID: 317051

[Dangerous thrombocytopenia in thrombolytic therapy of venous thrombosis of the leg] Keywords Mesh Terms:

KEYWORDS: Thrombophlebitis

MESH TERMS: drug therapy

Chemical & Substance for Abstract: [Dangerous thrombocytopenia in thrombolytic therapy of venous thrombosis of the leg] Information

Substance Name: Streptokinase

Registry Number: EC 3.4.-

Grant and Affiliation Information for [Dangerous thrombocytopenia in thrombolytic therapy of venous thrombosis of the leg]

AFFILIATION: Medizinische Klinik des Kreiskrankenhauses Neustadt am Rübenberge.

Country: SWITZERLAND

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Vasa

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Dangerous thrombocytopenia in thrombolytic therapy of venous thrombosis of the leg Related Publications

• Age limitation in human reproduction: is it justified?
• Assisted reproductive technology in Israel.
• Danger in the (farm) dust.
• Effect of acute ammonia intoxication on energy stores in the cerebral reticular activating system.
• Effects of liver disease and of aging on the disposition and elimination of sedatives.
• Ethical aspects of assisted reproduction in AIDS patients.
• Gender selection: cultural and religious perspectives.
• Genetic engineering: moral aspects and control of practice.
• Heterotopic pregnancy and assisted reproduction--an update.
• Legal aspects of ART practice in Israel.
• Methodology of human embryo transfer following assisted reproduction.
• Multiple imputation for national public-use datasets and its possible application for gestational age in United States Natality files.
• Ovum donation--an overview.
• Pathologic implications of abnormal stance and gait.
• Physical medicine patents.
• Physical medicine patents.
• Religious views regarding treatment of infertility by assisted reproductive technologies.
• Reproductive health care policies around the world. Is human cloning justified?
• Responsivity of schizophrenic men to pituitary adrenocorticotrophin.
• Sperm, oocyte, and pre-embryo donation.
• Surrogate practice in Israel: suggestions for regulation.
• The current status of sperm donation in assisted reproduction technology: ethical and legal considerations.
• The duties of ethical committees applied to human reproduction.
• [Dangerous thrombocytopenia in thrombolytic therapy of venous thrombosis of the leg]
• [Efficacy of morclofon, an new synthetic antitussive agent, in geriatric patients. Results of a double-blind study]
• [Not Available.]
• [Shock]
• [The drug problem]
• [The drug problem]
• [Thoughts on the original title about our voluntary aid in the Baltic war]